The Neisseria meningitidis Macrophage Infectivity Potentiator Protein Induces Cross-Strain Serum Bactericidal Activity and Is a Potential Serogroup B Vaccine Candidate

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Infection and Immunity

• Publication date

  2011-06-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.05019-11PMID 21708989PMCID PMC3165472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo

  2011cited by this paper
• Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival

  2011cited by this paper
• Potential of Recombinant Opa Proteins as Vaccine Candidates against Hyperinvasive Meningococci

  2011cited by this paper
• Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

  2010cited by this paper
• Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.

  2010cited by this paper
• Review of meningococcal group B vaccines.

  2010cited by this paper
• Immunoproteomic Analysis of the Development of Natural Immunity in Subjects Colonized by Neisseria meningitidis Reveals Potential Vaccine Candidates

  2009cited by this paper
• Vaccinology in the genome era.

  2009cited by this paper
• Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.

  2009cited by this paper
• Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant

  2008cited by this paper
• Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

  2008cited by this paper
• Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.

  2006cited by this paper
• A universal vaccine for serogroup B meningococcus.

  2006cited by this paper
• The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB

  2006cited by this paper
• Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

  2006cited by this paper
• Long-term protection in children with meningococcal C conjugate vaccination: lessons learned

  2006cited by this paper
• Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant

  2006cited by this paper
• Ng‐MIP, a surface‐exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl‐prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages

  2005influential reference
• Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein

  2004cited by this paper
• Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students

  2004cited by this paper
• The PPIase Active Site of Legionella pneumophila Mip Protein Is Involved in the Infection of Eukaryotic Host Cells

  2003influential reference
• Biochemical and Functional Analyses of the Mip Protein: Influence of the N-Terminal Half and of Peptidylprolyl Isomerase Activity on the Virulence of Legionella pneumophila

  2003influential reference
• Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection.

  2003cited by this paper
• Structures of immunophilins and their ligand complexes.

  2003cited by this paper
• Outer membrane vesicles from Neisseria meningitidis

  2002cited by this paper
• Neisseria meningitidis serogroup B: laboratory correlates of protection.

  2002cited by this paper
• Immunization with the Recombinant PorB Outer Membrane Protein Induces a Bactericidal Immune Response against Neisseria meningitidis

  2002cited by this paper
• NMR solution structure and dynamics of the peptidyl-prolyl cis-trans isomerase domain of the trigger factor from Mycoplasma genitalium compared to FK506-binding protein.

  2002cited by this paper
• Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed α‐helix

  2002cited by this paper
• Regulation of the Legionella mip-promotor during infection of human monocytes.

  2002cited by this paper
• Immunolocalization of the Mip protein of intracellularly and extracellularly grown Legionella pneumophila

  2001influential reference
• Immunization with Recombinant Opc Outer Membrane Protein from Neisseria meningitidis: Influence of Sequence Variation and Levels of Expression on the Bactericidal Immune Response against Meningococci

  2001cited by this paper
• Crystal structure of Mip, a prolylisomerase from Legionella pneumophila

  2001cited by this paper
• Recombinant proteins in vaccine development.

  2001cited by this paper
• Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.

  1998cited by this paper
• Synthesis in Escherichia coli of two smaller enzymically active analogues of Coxiella burnetii macrophage infectivity potentiator (CbMip) protein utilizing a single open reading frame from the cbmip gene.

  1998cited by this paper
• Specificity of Bactericidal Antibody Response to Serogroup B Meningococcal Strains in Brazilian Children after Immunization with an Outer Membrane Vaccine

  1998cited by this paper
• Decreased intracellular survival of an fkpA mutant of Salmonella typhimurium Copenhagen

  1997cited by this paper
• A 28 kDa major immunogen of Chlamydia psittaci shares identity with Mip proteins of Legionella spp. and Chlamydia trachomatis-cloning and characterization of the C. psittaci mip-like gene.

  1996cited by this paper
• Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100.

  1996cited by this paper
• Detection of mip-like sequences and mip-related proteins within the family Rickettsiaceae

  1995cited by this paper
• Secretion by Trypanosoma cruzi of a peptidyl‐prolyl cis‐trans isomerase involved in cell infection.

  1995cited by this paper
• The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis.

  1995influential reference
• Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.

  1993cited by this paper
• Immunophilins: structure—function relationship and possible role in microbial pathogenicity

  1993cited by this paper
• Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants.

  1992influential reference
• Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages

  1992cited by this paper
• Mip protein of Legionella pneumophila exhibits peptidyl‐prolyl‐cis/trans isomerase (PPIase) activity

  1992cited by this paper
• Cross‐reactive Legionella antigens and the antibody response during infection

  1991cited by this paper
• Chemistry and biology of the immunophilins and their immunosuppressive ligands.

  1991cited by this paper
• Rapamycin and FK506 binding proteins (immunophilins)

  1991cited by this paper
• Point mutation in meningococcal por A gene associated with increased endemic disease.

  1991cited by this paper
• Chlamydia trachomatis contains a protein similar to the Legionella pneumophila mip gene product

  1991cited by this paper
• The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans isomerase.

  1990cited by this paper
• A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection

  1989cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper
• Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

  1983cited by this paper
• Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels

  1983cited by this paper
• Structural comparison of Neisseria gonorrhoeae outer membrane proteins

  1981cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper

• Antigenicity in mice of a recombinant Neisseria gonorrhoeae MafA 2/3 protein

  2025cites this paper
• Identification of active main metabolites of anti‐infective inhibitors of the macrophage infectivity potentiator protein by liquid chromatography using mass detection

  2024cites this paper
• Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei.

  2023cites this paper
• Update on the Neisseria Macrophage Infectivity Potentiator-Like PPIase Protein

  2022cites this paper
• Synergistic activity of antibodies in the multicomponent 4CMenB vaccine

  2022cites this paper
• The potential utility of liposomes for Neisseria vaccines

  2021cites this paper
• Targeting protein folding; a novel approach for the treatment of pathogenic bacteria.

  2020cites this paper
• MOMP and MIP DNA-loaded bacterial ghosts reduce the severity of lung lesions in mice after Chlamydia psittaci respiratory tract infection.

  2019cites this paper
• Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus

  2019cites this paper
• 1 Meningococcal Vaccines : Current Status and 2 Emerging Strategies 3

  2018cites this paper
• Understanding and exploiting lipoprotein translocation in Gram negative pathogens for improved vaccine antigen delivery platforms

  2018cites this paper
• Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci

  2018cites this paper
• Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae

  2018cites this paper
• Meningococcal Vaccines: Current Status and Emerging Strategies

  2018cites this paper
• Neisseria gonorrhoeae employs two protein inhibitors to evade killing by human lysozyme

  2018cites this paper
• Solid sorbitan esters nanoparticles are efficient and low-cost vehicles for subunit vaccines: Proof of concept with Neisseria meningitidis protein Mip

  2017cites this paper
• Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine.

  2017cites this paper
• Liposomes or traditional adjuvants: induction of bactericidal activity by the macrophage infectivity potentiator protein (Mip) of Neisseria meningitidis

  2017cites this paper
• Neisserial surface lipoproteins: structure, function and biogenesis

  2017cites this paper
• Novel approaches to Neisseria meningitidis vaccine design.

  2017cites this paper
• Atividade antimicrobiana do óleo essencial de Ocimum americanum e Ocimum basilicum sobre periodontopatógenos

  2016cites this paper
• Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis

  2016cites this paper
• Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity.

  2016cites this paper
• Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis/trans isomerase (PPIase) proteins

  2015cites this paper
• In silico analysis and modeling of ACP-MIP-PilQ chimeric antigen from Neisseria meningitidis serogroup B.

  2015cites this paper
• Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates

  2015cites this paper
• A putative amino acid ABC transporter substrate-binding protein, NMB1612, from Neisseria meningitidis, induces murine bactericidal antibodies against meningococci expressing heterologous NMB1612 proteins.

  2015cites this paper
• Recombinant Protein Truncation Strategy for Inducing Bactericidal Antibodies to the Macrophage Infectivity Potentiator Protein of Neisseria meningitidis and Circumventing Potential Cross-Reactivity with Human FK506-Binding Proteins

  2014cites this paper
• Neisseria proteomics for antigen discovery and vaccine development

  2014cites this paper
• Microbial Peptidyl-Prolyl cis/trans Isomerases (PPIases): Virulence Factors and Potential Alternative Drug Targets

  2014cites this paper
• Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.

  2014cites this paper
• Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.

  2014cites this paper
• and Potential Alternative Drug Targets Isomerases ( PPIases ) : Virulence Factors trans / cis Microbial Peptidyl-Prolyl

  2014cites this paper
• Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.

  2013cites this paper
• The Adhesin Complex Protein (ACP) of Neisseria meningitidis Is a New Adhesin with Vaccine Potential

  2013cites this paper
• Correction: Transcriptional Profiling of Serogroup B Neisseria meningitidis Growing in Human Blood: An Approach to Vaccine Antigen Discovery

  2012cites this paper
• Advances with vaccination against Neisseria meningitidis

  2012cites this paper
• Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.

  2012cites this paper
• Advances in meningococcal vaccines

  2012cites this paper
• Investigation of the Distribution, Antigenic Variation and the Biological Role of Phase Variation of the Haemoglobin Receptors of Neisseria Meningitidis

  2012influential citation
• Transcriptional Profiling of Serogroup B Neisseria meningitidis Growing in Human Blood: An Approach to Vaccine Antigen Discovery

  2012cites this paper
• Proteomics of Protein Secretion by Aggregatibacter actinomycetemcomitans

  2012cites this paper
• Composition immunogène comprenant une protéine de potentiateur d'infectiosité de macrophage de neisseria menigitidis

  2011cites this paper